Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer

Published:2018-10-12 Issue:11 Volume:12 Page:1917-1934
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Liang Sitai¹,Medina Edward A.²,Li Boajie³,Habib Samy L.¹⁴

Affiliation:

1. Department of Cell Systems & Anatomy University of Texas Health Science Center at San Antonio TX USA

2. Department of Pathology and Laboratory Medicine University of Texas Health Science Center at San Antonio TX USA

3. Bio‐X Institutes Shanghai Jiao Tong University China

4. South Texas Veterans Health Care System San Antonio TX USA

Funder

University of Texas Health Science Center at San Antonio

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12370

Reference48 articles.

1. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging

2. Akt1/protein kinase B is critical for ischemic and VEGF-mediated angiogenesis

3. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells

4. Perturbations of the AKT signaling pathway in human cancer

5. The hV ps34‐ SGK 3 pathway alleviates sustained PI 3K/Akt inhibition by stimulating mTORC 1 and tumour growth

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis;Frontiers in Immunology;2023-10-16

2. Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma;Scientific Reports;2023-09-25

3. Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2023-04-08

4. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma;International Journal of Molecular Sciences;2023-03-13

5. Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma;Frontiers in Oncology;2021-11-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3